Evidence map›Paper›PMID 41901291›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics.

Aleksandar M Veselinović, Giulia Culletta, Jelena V Živković, Slavica Sunarić, Žarko Mitić, Muhammad Sohaib Roomi, Marco Tutone

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aleksandar M VeselinovićDepartment of Chemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.ORCID 0000-0001-9291-6654
Giulia CullettaDipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, via Archirafi, 28, 90123 Palermo, Italy.ORCID 0000-0001-9564-3962
Jelena V ŽivkovićDepartment of Chemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.ORCID 0000-0002-1130-2173
Slavica SunarićDepartment of Chemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
Žarko MitićDepartment of Chemistry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
Muhammad Sohaib RoomiDipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, via Archirafi, 28, 90123 Palermo, Italy.ORCID 0000-0001-6444-1655
Marco TutoneDipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, via Archirafi, 28, 90123 Palermo, Italy.ORCID 0000-0001-5059-8686

Funding

European Union-NextGenerationEU through the Italian Ministry of University and Research under PNRR-M4C2-I1.3 Project PE_00000019 "HEAL ITALIA"Ministry of Education and Science, the Republic of Serbia and the Faculty of Medicine, University of Niš, Republic of Serbia project No. 70Ministry of Education, Science and Technological Development of Republic of Serbia 451-03-47/2025-01/200113
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug designmajor depressive disordermolecular modelingQSARserotonin transporter

Identifiers

PMID41901291
PMCPMC13029183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.